Reuslts about the use of gemcitabine puls irinotecan as frist line in the treatment of pancreatic cancer are discussed
Gemcitabine plus irinotecan as first line weekly therapy in locally advanced and/or metastatic pancreatic cancer / Pantalone D, Bechi P, Taddei A, Ardu U, Grifoni R, Molinara E, Tonelli P, Neri B,. - STAMPA. - Proceedings:(2008), pp. 189-189. (Intervento presentato al convegno 2008 GASTROINTESTINAL CANCERS SYMPOSIUM -SCIENCES AND MULTIDICIPLINARY MANAGEMENT OF GI MALIGNANCIES-ASCO, ASTRO, SSO tenutosi a Orlado (Florida USA) nel 27-27 January 2008).
Gemcitabine plus irinotecan as first line weekly therapy in locally advanced and/or metastatic pancreatic cancer
Pantalone D
;Bechi P;Taddei A;ARDU, UBALDO;Molinara E;Tonelli P;Neri B
2008
Abstract
Reuslts about the use of gemcitabine puls irinotecan as frist line in the treatment of pancreatic cancer are discussed
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
